Tetrahydrobiopterin disorders presenting with hyperphenylalaninemia

Congenital Neurotransmitter Disorders: A Clinical Approach

Volumn , Issue , 2014, Pages 39-50

  Burlina, Alberto ^a   Blau, Nenad ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84955647988     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (36)

1. Blau, N; Thöny, B; Cotton, RGH; Hyland, K. Disorders of tetrahydrobiopterin and related biogenic amines. In: CR; Scriver, AL; Beaudet, WS; Sly, D; Valle, B; Childs, B; Vogelstein, eds. The Metabolie and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw-Hill, 2001, 1725-1776.
2. Opladen, T; Hoffmann, FG; Blau, N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inerit Metab Dis, 2012, 35, 963-973.
3. Smith, I; Dhondt, JL. Birthweight in patients with defective biopterin metabolism. Lancet, 1985, 1, 818.
4. Dhondt, JL. Tetrahydrobiopterin deficiencies. Lessons from the compilation of 200 patients. Dev Brain Disfunct, 1993, 6, 139-155.
5. Blau, N; Heizmann, CW; Sperl, W; et al. Atypical (mild) forms of dihydropteridine reductase deficiency-Neurochemical evaluation and mutation detection. Pediatr Res, 1992, 32, 726-730.
6. Dhondt, JL; Guibaud, P; Rolland, MO; et al. Neonatal hyperphenylalaninaemia presumably caused by a new variant of biopterin synthetase deficiency. European Journal of Pediatrics, 1988, 147, 153-157.
7. Blaskovics, M; Giudici, TA. A new variant of biopterin deficiency. N Engl J Med, 1988, 319, 1611-1612.
8. Simaite, D; Kofent, J; Gong, M; et al. Recessive mutations in PCBD1 cause a new type of early-onset diabetes. Diabetes, 2014, DOI: 10.2337/db13-1784.
9. Ye, J; Yang, Y; Yu, W; et al. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study. J Inherit Metab Dis, 2012.
10. Niederwieser, A; Blau, N; Wang, M; Joller, P; Atares, M; Cardesa-Garcia, J. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. European Journal of Pediatrics, 1984, 141, 208-214.
11. Blau, N; Ichinose, H; Nagatsu, T; Heizmann, CW; Zacchello, F; Burlina, AB. A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program. J Pediatr, 1995, 126, 401-405.
12. Blau, N; van Spronsen, F. Disorders of phenylalanine and tetrahydrobiopterin metabolism. In: Blau N; Duran M; Gibson KM; Dionisi-Vici C; eds. Physician's Guide to the Diagnosis, Treatment, and Follow-up of Inherited Metabolic Diseases. Berlin-Heidelberg: Springer-Verlag, 2014, 3-21.
13. Ozand, PT. Hyperphenylalaninemia and defective metabolism of tetrahydrobiopterin. In: Nyhan WL; Ozand PT; eds. Atlas of Metabolic Disease. London: Chapman & Hall Medical, 1998, 117-125.
14. al Aqeel, A; Ozand, PT; Gascon, G; et al. Biopterin-dependent hyperphenylalaninemia due to deficiency of 6-pyruvoyl tetrahydropterin synthase. Neurology, 1991, 41, 730-737.
15. Hanihara, T; Inoue, K; Kawanishi, C; et al. 6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms-a clinical and molecular study. Movement Dis, 1997, 12, 408-411.
16. Leuzzi, V; Carducci, C; Pozzessere, S; et al. Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency. Clin Genet, 2010, 77, 249-257.
17. Ponzone, A; Blau, N; Guardamagna, O; Ferrero, GB; Dianzani, I; Endres, W. Progression of 6-pyruvoyl-tetrahydropterin synthase deficiency from a peripheral into a central phenotype. J Inherit Metab Dis, 1990, 13, 298-300.
18. Jäggi, L; Zurflüh, MR; Schuler, A; et al. Outcome and long-term follow-up of 36 patients with tetrahydrobiopterin deficiency. Mol Genet Metab, 2008, 93, 295-305.
19. Woody, RC; Brewster, MA; Glasier, C. Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy. Neurology, 1989, 39, 673-675.
20. Coskun, T; Besim, A; Özalp, I; Erylimaz, M. Intracranial calcifications in dihydropteridine reductase deficiency. Turk J Pediatr, 1990, 32, 259-264.
21. Ponzone, A; Spada, M; Ferraris, S; Dianzani, I; De Sanctis, L. Dihydropteridine reductase deficiency in man: From biology to treatment. Med Res Rev, 2004, 24, 127-150.
22. Sedel, F; Ribeiro, MJ; Remy, P; Blau, N; Saudubray, JM; Agid, Y. Dihydropteridine reductase deficiency: Levodopa's long-term effectiveness without dyskinesia. Neurology, 2006, 67, 2243-2245.
23. Friedman, J; Hyland, K; Blau, N; Jenkins, B; MacCollin, M. CNS dihydropteridine reductase deficiency associated with diurnal dystonia and hypersomnolence. AAN Abstract Book, 1999.
24. Werner, ER; Blau, N; Thöny, B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J, 2011, 438, 397-414.
25. Tatham, AL; Crabtree, MJ; Warrick, N; Cai, S; Alp, NJ; Channon, KM. GTP cyclohydrolase I expression, protein and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression. Journal of Biological Chemistry, 2009, 284, 13660-13668.
26. 4-metabolizing genes GTP cyclohydroalse I; 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase genes. Human Mutat, 2006, 27, 870-878.
27. Blau, N; Burton, KB; Thöny, B; Van Spronsen, FJ; Waisbren SE. Phenylketonuria and BH4 Deficiencies. Bremen: UNI-MED Verlag AG, 2010.
28. Opladen, T; Abu Seda, B; Rassi, A; Thony, B; Hoffmann, GF; Blau, N. Diagnosis of tetrahydrobiopterin deficiency using filter paper blood spots: further development of the method and 5 years experience. J Inherit Metab Dis, 2011, 34, 819-826.
29. 4) deficiencies. Mol Genet Metab, 2011, 104, S2-9.
30. 4) and diacetyl BH4. Pediatr Res, 1982, 16, 694.
31. Coughlin, CR; 2nd, Hyland, K; Randall, R; Ficicioglu, C. Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: a case report. JIMD Rep, 2013, 10, 53-56.
32. Longo, N. Disorders of biopterin metabolism. J Inherit Metab Dis, 2009, 32, 333-342.
33. Ng, J; Heales, SJ; Kurian, MA. Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Paediatr Drugs, 2014, 16, 275-291.
34. Porta, F; Mussa, A; Concolino, D; Spada, M; Ponzone, A. Dopamine agonists in 6-pyruvoyl tetrahydropterin synthase deficiency. Neurology, 2009, 73, 633-637.
35. Dudesek, A; Röschinger, W; Muntau, AC; et al. Molecular analysis and long term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. European Journal of Pediatrics, 2001, 160, 267-276.
36. Wang, L; Yu, WM; He, C; et al. Long-term outcome and neuroradiological findings of 31 patients with 6-pyruvoyltetrahydropterin synthase deficiency. J Inherit Metab Dis, 2006, 29, 127-134.